Signaling of the human P2Y1 receptor measured by a yeast growth assay with comparisons to assays of phospholipase C and calcium mobilization in 1321N1 human astrocytoma cells
Open Access
- 29 July 2005
- journal article
- Published by Springer Nature in Purinergic Signalling
- Vol. 1 (3), 241-247
- https://doi.org/10.1007/s11302-005-6310-1
Abstract
The human P2Y1 receptor was expressed in the yeast Saccharomyces cerevisiae strain MPY578q5, which is engineered to couple to mammalian G protein-coupled receptors (GPCRs) and requires agonist-induced activation for growth. A range of known P2Y1 receptor agonists were examined with the yeast growth assay system, and the results were validated by comparing with potencies in the transfected 1321N1 astrocytoma cell line, in which calcium mobilization was measured with a FLIPR (fluorometric-imaging plate reader). The data were also compared with those from phospholipase C activation and radioligand binding with the use of a newly available radioligand [3H]MRS2279 (2-chloro-N 6-methyl-(N)-methanocarba-2’-deoxyadenosine-3’,5’bisphosphate). In the yeast growth assay, the rank order of potency of 2-MeSADP (2-methylthioadenosine 5’-diphosphate), ADP (adenosine 5’-diphosphate), and ATP (adenosine 5’-triphosphate) is the same as those in other assay systems, i.e., 2-MeSADP>ADP>ATP. The P2Y1-selective antagonist MRS2179 (N 6-methyl-2-deoxyadenosine-3’,5’-bisphosphate) was shown to act as an antagonist with similar potency in all systems. The results suggest that the yeast expression system is suitable for screening P2Y1 receptor ligands, both agonists and antagonists. The yeast system should be useful for random mutagenesis of GPCRs to identify mutants with certain properties, such as selective potency enhancement for small synthetic molecules and constitutive activity.Keywords
This publication has 35 references indexed in Scilit:
- Functional expression of human and mouse P2Y12 receptors in Saccharomyces cerevisiaeBiochemical and Biophysical Research Communications, 2004
- The state of GPCR research in 2004Nature Reviews Drug Discovery, 2004
- Random Mutagenesis of the Human Adenosine A2B Receptor Followed by Growth Selection in Yeast. Identification of Constitutively Active and Gain of Function MutationsPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Comparative Analysis of Functional Assays for Characterization of Agonist Ligands at G Protein–Coupled ReceptorsSLAS Discovery, 2003
- Random Mutagenesis of the M3 Muscarinic Acetylcholine Receptor Expressed in YeastJournal of Biological Chemistry, 2003
- Yeast Assays for G-Protein-Coupled ReceptorsReceptors and Channels, 2002
- Role of the Extracellular Loops of G Protein-Coupled Receptors in Ligand Recognition: A Molecular Modeling Study of the Human P2Y1 ReceptorBiochemistry, 1999
- Human P2Y1 Receptor: Molecular Modeling and Site-Directed Mutagenesis as Tools To Identify Agonist and Antagonist Recognition SitesJournal of Medicinal Chemistry, 1998
- Deoxyadenosine Bisphosphate Derivatives as Potent Antagonists at P2Y1 ReceptorsJournal of Medicinal Chemistry, 1998
- Structure activity relationships for derivatives of adenosine‐5′‐triphosphate as agonists at P2 purinoceptors: Heterogeneity within P2x and P2y subtypesDrug Development Research, 1994